Last checked at 
2 Sep 2020 07:00
LEI: 549300Q7EXQQH6KF7Z84
2 September 2020
RTW Venture Fund Limited
Notice of Interim Report
RTW Venture Fund Limited (the "Company") advises that it will publish its Half Year Results for the period ended 30 June 2020 (the "Interim Report") on 24 September 2020.
A conference call for analysts will be held at 2 pm BST / 9 am EST on the day. To register for the event please RSVP to georgeb@buchanan.uk.com.
For Further Information
RTW Investments, LP +1 (646) 343 9280Stephanie Sirota, Chief Business OfficerAlexandra Taracanova, PhD, Director of Investor Relations
Julia Enright, Business Development Associate
Buchanan +44 (0)20 7466 5000Charles Ryland
Henry Wilson
George Beale
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading US healthcare investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more information.